{"transactions":[{"id":4634526,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-10-03T00:30:51.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.36,"value":95400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $6.20 to $6.48. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote."}],"balance_after":1119402,"source":{"system":"sec-edgar","filing":"0001104659-26-113320","document":"tm2626947-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926113320/tm2626947-1_4seq1.xml","form_type":"4"}},{"id":469,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-09-02T20:15:20.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":4.94,"value":74100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote."}],"balance_after":1134402,"source":{"system":"sec-edgar","filing":"0001104659-26-104739","document":"tm2624698-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926104739/tm2624698-1_4seq1.xml","form_type":"4"}},{"id":673044,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-28T20:15:51.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":5.33,"value":10660.0,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-26-103209","document":"tm2624220-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926103209/tm2624220-2_4seq1.xml","form_type":"4"}},{"id":673043,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-08-28T20:15:51.000Z","date":"2026-08-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4925,"price":5.26,"value":25905.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1149402,"source":{"system":"sec-edgar","filing":"0001104659-26-103209","document":"tm2624220-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926103209/tm2624220-2_4seq1.xml","form_type":"4"}},{"id":697319,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-04T20:49:57.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":4.09,"value":61350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $3.94 to $4.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote."}],"balance_after":1154327,"source":{"system":"sec-edgar","filing":"0001104659-26-090449","document":"tm2622228-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926090449/tm2622228-1_4seq1.xml","form_type":"4"}},{"id":718170,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-07-02T20:15:23.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":4.27,"value":64050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.21 to $4.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote."}],"balance_after":1169327,"source":{"system":"sec-edgar","filing":"0001104659-26-080333","document":"tm2619667-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926080333/tm2619667-1_4seq1.xml","form_type":"4"}},{"id":754998,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-02T20:27:37.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":3.87,"value":58050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $3.81 to $4.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote."}],"balance_after":1184327,"source":{"system":"sec-edgar","filing":"0001104659-26-069503","document":"tm2616712-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926069503/tm2616712-1_4seq1.xml","form_type":"4"}},{"id":758821,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-29T20:15:30.000Z","date":"2026-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4925,"price":3.98,"value":19601.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1199327,"source":{"system":"sec-edgar","filing":"0001104659-26-068274","document":"tm2616050-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926068274/tm2616050-1_4seq1.xml","form_type":"4"}},{"id":826424,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-03-27T20:31:25.000Z","date":"2026-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":33317,"price":4.57,"value":152258.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1204252,"source":{"system":"sec-edgar","filing":"0001104659-26-036168","document":"tm269936-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926036168/tm269936-3_4seq1.xml","form_type":"4"}},{"id":905340,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-13T22:01:46.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":397000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 25% of the shares will vest 18 months after February 12, 2026 (the \"Issue Date\"), (ii) 25% of the shares will vest 24 months after the Issue Date, (iii) 25% of the shares will vest 30 months after the Issue Date and (iv) 25% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":1237569,"source":{"system":"sec-edgar","filing":"0001104659-26-015323","document":"tm266316-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926015323/tm266316-3_4seq1.xml","form_type":"4"}},{"id":916095,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2026-02-06T21:15:16.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":34974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This date represents the date of vesting of a performance stock option granted on April 23, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the \"Vesting Commencement Date\") with the remaining 75% vesting in equal installments every three months thereafter on the same day of the month as the Vesting Commencement Date over a three-year period, commencing in the third month after the Vesting Commencement Date."}],"balance_after":34974,"derivative":{"exercise_price":2.85,"expiration_date":"2035-04-23","underlying":"Common Stock","underlying_shares":34974},"source":{"system":"sec-edgar","filing":"0001104659-26-011524","document":"tm265397-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926011524/tm265397-1_4seq1.xml","form_type":"4"}},{"id":955266,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-02T23:53:59.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":5588,"price":4.31,"value":24084.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":840569,"source":{"system":"sec-edgar","filing":"0001104659-26-000269","document":"tm261746-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926000269/tm261746-1_4seq1.xml","form_type":"4"}},{"id":987239,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-11-26T21:05:16.000Z","date":"2025-11-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":40340,"price":5.35,"value":215819.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":846157,"source":{"system":"sec-edgar","filing":"0001104659-25-116428","document":"tm2532314-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925116428/tm2532314-1_4seq1.xml","form_type":"4"}},{"id":1046856,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-09-05T20:15:24.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":40340,"price":2.72,"value":109724.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":886497,"source":{"system":"sec-edgar","filing":"0001104659-25-087810","document":"tm2525310-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925087810/tm2525310-1_4seq1.xml","form_type":"4"}},{"id":1056862,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-08-25T23:04:17.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":2.62,"value":7860.0,"ownership":{"direct":true},"balance_after":926837,"source":{"system":"sec-edgar","filing":"0001104659-25-082636","document":"tm2524324-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925082636/tm2524324-3_4seq1.xml","form_type":"4"}},{"id":1071431,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-08T23:15:55.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":923837,"source":{"system":"sec-edgar","filing":"0001104659-25-075787","document":"tm2523004-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075787/tm2523004-8_4seq1.xml","form_type":"4"}},{"id":1129344,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-05-30T21:32:38.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":45843,"price":2.95,"value":135236.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":803837,"source":{"system":"sec-edgar","filing":"0001104659-25-055019","document":"tm2516689-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925055019/tm2516689-1_4seq1.xml","form_type":"4"}},{"id":1177724,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-04-05T01:39:18.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":115708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the \"Issue  Date\"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":849680,"source":{"system":"sec-edgar","filing":"0001104659-25-032331","document":"tm2511637-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925032331/tm2511637-2_4seq1.xml","form_type":"4"}},{"id":1340566,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-12-06T21:49:24.000Z","date":"2024-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":31815,"price":5.57,"value":177209.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units."}],"balance_after":733972,"source":{"system":"sec-edgar","filing":"0001104659-24-126333","document":"tm2430395-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924126333/tm2430395-1_4seq1.xml","form_type":"4"}},{"id":1410921,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-10T23:45:35.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":6904,"price":5.31,"value":36660.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.13 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":765787,"source":{"system":"sec-edgar","filing":"0001104659-24-098693","document":"tm2423769-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924098693/tm2423769-2_4seq1.xml","form_type":"4"}},{"id":1410920,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-09-10T23:45:35.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":6804,"price":5.48,"value":37285.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.57, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the \"SEC\"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":772691,"source":{"system":"sec-edgar","filing":"0001104659-24-098693","document":"tm2423769-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924098693/tm2423769-2_4seq1.xml","form_type":"4"}},{"id":1412801,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-06T23:31:13.000Z","date":"2024-09-06","kind":"sale","planned":false,"acquired":false,"shares":6819,"price":5.65,"value":38527.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":779495,"source":{"system":"sec-edgar","filing":"0001104659-24-097862","document":"tm2423573-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924097862/tm2423573-1_4seq1.xml","form_type":"4"}},{"id":1412800,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-06T23:31:13.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":6961,"price":5.85,"value":40721.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.61 to $6.14, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":786314,"source":{"system":"sec-edgar","filing":"0001104659-24-097862","document":"tm2423573-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924097862/tm2423573-1_4seq1.xml","form_type":"4"}},{"id":1412799,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-09-06T23:31:13.000Z","date":"2024-09-04","kind":"sale","planned":false,"acquired":false,"shares":6837,"price":6.1,"value":41705.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.19, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the \"SEC\"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":793275,"source":{"system":"sec-edgar","filing":"0001104659-24-097862","document":"tm2423573-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924097862/tm2423573-1_4seq1.xml","form_type":"4"}},{"id":1520867,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-05-10T21:22:14.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":176667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 26,500 RSUs will vest on May 25, 2025, and (ii) the remaining 150,167 RSUs will vest in equal installments on August 25, 2025, November 25, 2025, December 22, 2025, May 25, 2026, August 25, 2026, December 22, 2026, March 25, 2027, May 25, 2027, August 25, 2027, November 25, 2027, March 25, 2028 and May 25, 2028, subject to the Reporting Person's continuous service through such dates."}],"balance_after":800112,"source":{"system":"sec-edgar","filing":"0001104659-24-060000","document":"tm2414108-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924060000/tm2414108-3_4seq1.xml","form_type":"4"}},{"id":1824230,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-07-24T21:12:45.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":539667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the \"Vesting Commencement Date\"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":623445,"source":{"system":"sec-edgar","filing":"0001104659-23-083504","document":"tm2321855-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083504/tm2321855-9_4seq1.xml","form_type":"4"}},{"id":1884799,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:38:15.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":116250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of two classes of nonstatutory stock options (\"NSOs\") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The NSOs vest over a three-year period as follows: (i) 44.4% of the underlying shares vested on the grant date and (ii) 55.6% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting with March 31, 2023, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023."}],"balance_after":116250,"derivative":{"exercise_price":10,"expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":116250},"source":{"system":"sec-edgar","filing":"0001213900-23-041609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041609/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1884798,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:38:15.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":508397,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of two classes of nonstatutory stock options (\"NSOs\") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 1,093,327 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":508397,"derivative":{"exercise_price":10,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":508397},"source":{"system":"sec-edgar","filing":"0001213900-23-041609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041609/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902966,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-06T00:07:46.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":29918,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."}],"balance_after":29918,"derivative":{"underlying":"Common Stock","underlying_shares":29918},"source":{"system":"sec-edgar","filing":"0001213900-23-037010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037010/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902965,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-05-06T00:07:46.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":68819,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for 147,998 shares of common stock of Legacy Orchestra (\"Legacy Orchestra Common Stock\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."}],"balance_after":68819,"source":{"system":"sec-edgar","filing":"0001213900-23-037010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037010/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902956,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-05T23:35:46.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":14959,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":14959,"derivative":{"underlying":"Common Stock","underlying_shares":14959},"source":{"system":"sec-edgar","filing":"0001213900-23-036999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023036999/ownership.xml","form_type":"4"}},{"id":1902955,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-05-05T23:35:46.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":14959,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":83778,"source":{"system":"sec-edgar","filing":"0001213900-23-036999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023036999/ownership.xml","form_type":"4"}},{"id":2042286,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":6743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in the Business Combination in exchange for an incentive stock option to acquire 14,500 shares of Legacy Orchestra Common Stock for $1.89 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022."}],"balance_after":6743,"derivative":{"exercise_price":4.06,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":6743},"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2042285,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":116250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023."}],"balance_after":116250,"derivative":{"exercise_price":10,"expiration_date":"2023-01-19","underlying":"Common Stock","underlying_shares":116250},"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2042284,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":508397,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 1,093,327 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":508397,"derivative":{"exercise_price":10,"expiration_date":"2023-08-07","underlying":"Common Stock","underlying_shares":508397},"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2042283,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":46500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 100,000 shares of Legacy Orchestra Common Stock for $2.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The nonstatutory stock options (\"NSOs\") vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022."}],"balance_after":46500,"derivative":{"exercise_price":4.3,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":46500},"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2042282,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":310321,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 667,357 shares of Legacy Orchestra Common Stock for $2.00 per share."}],"balance_after":310321,"derivative":{"exercise_price":4.3,"exercise_date":"2023-01-26","expiration_date":"2028-08-07","underlying":"Common Stock","underlying_shares":310321},"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2042281,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-01-31T02:24:31.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":68189,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Business Combination in exchange for 147,998 shares of common stock of Legacy Orchestra (\"Legacy Orchestra Common Stock\")."}],"balance_after":68189,"source":{"system":"sec-edgar","filing":"0001213900-23-006176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006176/ownership.xml","form_type":"4"}},{"id":2401685,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T17:11:12.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\"). The option becomes exercisable as to 100% of the shares on February 10, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.46,"expiration_date":"2032-02-10","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-004066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315222004066/ownership.xml","form_type":"4"}},{"id":2440043,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-01-07T16:45:20.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":90521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 5, 2022, Reporting Person was granted 90,521 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":194602,"source":{"system":"sec-edgar","filing":"0001493152-22-000690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315222000690/ownership.xml","form_type":"4"}},{"id":2846321,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T16:16:05.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":30000,"derivative":{"exercise_price":1.78,"expiration_date":"2031-02-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-21-010583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010583/ownership.xml","form_type":"4"}},{"id":2846320,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:16:05.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":22191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 17, 2021, Reporting Person was granted 22,191 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":104081,"source":{"system":"sec-edgar","filing":"0001213900-21-010583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010583/ownership.xml","form_type":"4"}},{"id":2846319,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:16:05.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 17, 2021, Reporting Person was granted 30,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":81890,"source":{"system":"sec-edgar","filing":"0001213900-21-010583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010583/ownership.xml","form_type":"4"}},{"id":2907239,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-01-14T09:07:26.000Z","date":"2021-01-12","kind":"grant","acquired":true,"shares":9144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 12, 2021, Reporting Person was granted 9,144 shares of Common Stock as compensation for Reporting Persons service as a director during the fourth quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":51890,"source":{"system":"sec-edgar","filing":"0001213900-21-002120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021002120/ownership.xml","form_type":"4"}},{"id":2938012,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-18T09:01:22.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":3000,"price":0.97,"value":2910.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9656 to $0.97, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":42746,"source":{"system":"sec-edgar","filing":"0001213900-20-043390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020043390/ownership.xml","form_type":"4"}},{"id":3008324,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-10-13T17:03:14.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":10346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 12, 2020, Reporting Person was granted 10,346 shares of Common Stock as compensation for Reporting Persons service as a director during the third quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":39746,"source":{"system":"sec-edgar","filing":"0001213900-20-031109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020031109/ownership.xml","form_type":"4"}},{"id":3084390,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-07-13T16:19:51.000Z","date":"2020-07-10","kind":"grant","acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 10, 2020, Reporting Person was granted 7,900 shares of Common Stock as compensation for Reporting Persons service as a director during the second quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":29400,"source":{"system":"sec-edgar","filing":"0001213900-20-017345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020017345/ownership.xml","form_type":"4"}},{"id":3284643,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T16:41:11.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 50% of the shares on February 6, 2021, and the remaining shares will become exercisable on February 6, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In prior reports, Reporting Person reported indirect beneficial ownership of (A) 109,792 shares of Issuer Common Stock held by Orchestra Medical Ventures II, L.P. (\"OMV II\"), (B) a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II, (C) a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II, (D) 83,352 shares of Issuer Common Stock held by Orchestra Medical Ventures II Reserve, L.P. (\"OMV Reserve\"), (E) 1,159,968 shares of Issuer Common Stock held by Orchestra MOTUS Co-Investment Partners, LLC (\"OMCP\"), (F) a warrant to purchase 115,997 shares of Issuer Common Stock held by OMCP, and (G) a warrant to purchase 69,139 shares of Issuer Common Stock held by OMCP. Each of OMV II, OMV Reserve and OMCP distributed all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019 and Reporting Person retained no direct or indirect beneficial ownership of any shares of Issuer Common Stock or warrants to purchase shares of Issuer Common Stock pursuant to such pro rata distributions."}],"balance_after":12500,"derivative":{"exercise_price":2.16,"expiration_date":"2030-02-06","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-20-002937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002937/ownership.xml","form_type":"4"}},{"id":3284642,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-02-07T16:41:11.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2020, Reporting Person was granted 12,500 Common Stock restricted stock units. The restricted stock units vest as to 50% of the shares on February 6, 2021, and the remaining restricted stock unit shares vest on February 6, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In prior reports, Reporting Person reported indirect beneficial ownership of (A) 109,792 shares of Issuer Common Stock held by Orchestra Medical Ventures II, L.P. (\"OMV II\"), (B) a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II, (C) a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II, (D) 83,352 shares of Issuer Common Stock held by Orchestra Medical Ventures II Reserve, L.P. (\"OMV Reserve\"), (E) 1,159,968 shares of Issuer Common Stock held by Orchestra MOTUS Co-Investment Partners, LLC (\"OMCP\"), (F) a warrant to purchase 115,997 shares of Issuer Common Stock held by OMCP, and (G) a warrant to purchase 69,139 shares of Issuer Common Stock held by OMCP. Each of OMV II, OMV Reserve and OMCP distributed all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019 and Reporting Person retained no direct or indirect beneficial ownership of any shares of Issuer Common Stock or warrants to purchase shares of Issuer Common Stock pursuant to such pro rata distributions."}],"balance_after":21500,"source":{"system":"sec-edgar","filing":"0001213900-20-002937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002937/ownership.xml","form_type":"4"}},{"id":3653854,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T17:00:23.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\"). The option becomes exercisable as to 50% of the shares on February 13, 2020, and the remaining shares will become exercisable on February 13, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":25000,"derivative":{"exercise_price":4.3,"expiration_date":"2029-02-13","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001615774-19-002637","document":"s116115_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577419002637/s116115_form4.xml","form_type":"4"}},{"id":3908555,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-06-04T16:31:29.000Z","date":"2018-05-31","kind":"other","acquired":true,"shares":2000000,"ownership":{"direct":false,"nature":"By Orchestra BioMed, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The securities are directly held by OBIO. Reporting Person, Mr. Hochman and Geoffrey W. Smith are the directors of OBIO. OBIO exchanged 2,000,000 shares of Series A Preferred Stock of OBIO in return for (a) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from OMV II and (b) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from Ascent Biomedical Ventures II, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The securities are directly held by OBIO. Reporting Person, Mr. Hochman and Geoffrey W. Smith are the directors of OBIO. OBIO exchanged 2,000,000 shares of Series A Preferred Stock of OBIO in return for (a) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from OMV II and (b) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from Ascent Biomedical Ventures II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are directly held by OBIO. Reporting Person, Mr. Hochman and Mr. Smith are the directors of OBIO. Reporting Person, Mr. Hochman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Hochman and Mr. Smith disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0001615774-18-004821","document":"s110580_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004821/s110580_form4.xml","form_type":"4"}},{"id":3908554,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-06-04T16:31:29.000Z","date":"2018-05-31","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and David Hochman are the managing members of OMV GP. OMV II exchanged 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. in return for 1,000,000 shares of Series A Preferred Stock of Orchestra BioMed, Inc., a Delaware corporation (\"OBIO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and David Hochman are the managing members of OMV GP. OMV II exchanged 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. in return for 1,000,000 shares of Series A Preferred Stock of Orchestra BioMed, Inc., a Delaware corporation (\"OBIO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by OMV II. OMV GP serves as general partner to OMV II. Reporting Person and Mr. Hochman are the managing members of OMV GP. Reporting Person and Mr. Hochman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Hochman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (\"Section 16\"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Hochman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":109792,"source":{"system":"sec-edgar","filing":"0001615774-18-004821","document":"s110580_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004821/s110580_form4.xml","form_type":"4"}},{"id":3924124,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-05-21T08:02:04.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":1000,"price":5.55,"value":5550.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001615774-18-004109","document":"s110296_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004109/s110296_4.xml","form_type":"4"}},{"id":4044450,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"other","acquired":true,"shares":115997,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra MOTUS Co-Investment Partners, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The securities were acquired as consideration for entering into one or more agreements in connection with Company's initial public offering. Please see the Registration Statement for a complete description of the warrant terms and such agreements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC (\"OMCP\"). Orchestra Medical Ventures, LLC (\"OMV LLC\") serves as managing member to OMCP. Reporting Person and Darren Sherman are the managing partners of OMV LLC. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (\"Section 16\"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":115997,"derivative":{"exercise_price":5,"exercise_date":"2018-08-15","expiration_date":"2023-02-16","underlying":"Common Stock","underlying_shares":115997},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044449,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"other","acquired":true,"shares":106980,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The securities were acquired as consideration for entering into one or more agreements in connection with Company's initial public offering. Please see the Registration Statement for a complete description of the warrant terms and such agreements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":106980,"derivative":{"exercise_price":5,"exercise_date":"2018-08-15","expiration_date":"2023-02-16","underlying":"Common Stock","underlying_shares":106980},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044448,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"other","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The securities were acquired as consideration for entering into one or more agreements in connection with Company's initial public offering. Please see the Registration Statement for a complete description of the warrant terms and such agreements."}],"balance_after":300,"derivative":{"exercise_price":5,"exercise_date":"2018-08-15","expiration_date":"2023-02-16","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044447,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":65038,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra MOTUS Co-Investment Partners, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC (\"OMCP\"). Orchestra Medical Ventures, LLC (\"OMV LLC\") serves as managing member to OMCP. Reporting Person and Darren Sherman are the managing partners of OMV LLC. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (\"Section 16\"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":65038},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044446,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":99748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":99748},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044445,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of Motus GI Holdings, Inc. (\"Motus\"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the \"Registration Statement\") for a complete description of the conversion rights."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044444,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":true,"shares":65038,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra MOTUS Co-Investment Partners, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC (\"OMCP\"). Orchestra Medical Ventures, LLC (\"OMV LLC\") serves as managing member to OMCP. Reporting Person and Darren Sherman are the managing partners of OMV LLC. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (\"Section 16\"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":1159968,"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044443,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":true,"shares":99748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":1109792,"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044442,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on February 16, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person, together with Mr. Sherman, jointly exercises sole dispositive and sole voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":1010044,"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044441,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"exercise","acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}},{"id":4044440,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":435,"kind":"person","name":"Sherman Darren","position":1,"cik":"0001723524","reported_name":"Sherman Darren","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":5000,"price":5,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on February 16, 2018."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001493152-18-002417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002417/form4.xml","form_type":"4"}}]}